CoChat

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture

Open access
Toso, Christian, McCall, Michael, Emamaullee, Juliet, Merani, Shaheed, Davis, Joy, Edgar, Ryan, Pawlick, Rena, Kin, Tatsuya, Knudsen, Lotte B., Shapiro, AM James · 2010 · Transplant International
Cited by 79

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The culture of human islets is associated with approximately 10-20% islet loss, occasionally preventing transplantation. Preconditioning of the islets to improve postculture yields would be of immediate benefit, with the potential to increase both the number of transplanted patients and their metabolic reserve. In this study, the effect of liraglutide, a long-acting human glucagon-like peptide 1 analogue, on cultured human islets was examined. Culture with liraglutide (1 micromol/l) was associated with a preservation of islet mass (significantly more islets at 24 and 48 h, compared to control; P < or = 0.05 at 24 and 48 h) and with the presence of larger islets (P < or = 0.05 at 48 h). These observations were supported by reduced apoptosis rates after 24 h of treatment. We also demonstrated that human islet engraftment is improved in C57Bl/6-RAG(-/-) mice treated with liraglutide 200 microg/kg sc twice daily (P < or = 0.05), suggesting that liraglutide should be continued after transplantation. Overall, these data demonstrate the beneficial effect of liraglutide on cultured human islets, preserving islet mass. They support the design of clinical studies looking at the effect of liraglutide in clinical islet transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1432-2277.2009.00984.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 79

Metadata

Authors
Toso, C., McCall, M., Emamaullee, J., Merani, S., Davis, J., Edgar, R., Pawlick, R., Kin, T., Knudsen, L. B., & Shapiro, A. J.
Venue
Transplant International
Published
2010-03
Volume
23
Issue
3
Pages
259-265
ISSN
  • 0934-0874 (ISSN-L)
  • 1432-2277
OpenAlex
W2038234704
Cited by
79
References
4
FWCI
6.46
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. https://app.cochat.ai/papers/10.1111/j.1432-2277.2009.00984.x
The paper
Toso, C., McCall, M., Emamaullee, J., Merani, S., Davis, J., Edgar, R., Pawlick, R., Kin, T., Knudsen, L. B., & Shapiro, A. J. (2010). Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transplant International. https://doi.org/10.1111/j.1432-2277.2009.00984.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.